FDMT
4D MOLECULAR THE
Health Care·Biotechnology·UNITED STATES
$16.10
MCap $889.4M
as of 2026-08-20
Total
B2w
Fund
D8w
Quant
A8w
Price
▲ Up▼ Down━ MA30━ MA100━ Mean┄ U┄ L
MIDOS % pane · green > 90 long zone · red < 10 short zone · reference lines at 10 / 90
MIDOS SI
as of 2026-08-20
MIDOS SI
+0.03
Sentiment 41.8%
−3 oversold0+3 overbought
Signal
NEUTRAL
Actual
$16.10
Adaptive Mean
$16.07
+0.03 vs mean
Adaptive σ
0.63
MIDOS BB
$14.81 – $17.33
center ± 2σ adaptive
Fundamental Factors (Sector-Relative Z)
as of 2026-08-21
Composite Z
+0.80
ROE
-43.3%
Z -0.35
Rev Gr
25106.7%
Z +4.91
EPS Gr
—
Z -0.01
OPM Gr
380591.0%
Z +0.33
FCF Yld
-10.1%
Z —
EPS Surp
-0.0%
Z -0.10
EPS 3mo Δ
-3.3%
Z +0.01
Fwd P/E
-3.96
Z —
PEGY
N/A
growth + yield ≤ 0
Momentum (Risk-Adjusted Alpha)
as of 2026-08-21
Q3M
19.27
Q6M
8.11
Q12M
6.61
MA 30/100
1.101
Bullish (MA30 > MA100)
α (Jensen)
2.7711
β (12M)
1.94
σ (12M)
0.808
Momentum inflection: Q3M > Q12M
Divergence — Fundamentals vs Momentum
Z Percentile
96%
Q Percentile
86%
Divergence
+9.9
Tier
ALIGNED
Fundamentals and momentum roughly in line.
Kirkpatrick RS & Persistence
RS
60.0
RS Pctl
93%
RS Decile
D10
Persistence
2w
at grade B
Options / OI Analysis
No options or Williams data available for this ticker.